KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Profit After Tax (2017 - 2025)

Historic Profit After Tax for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$34.0 million.

  • Elanco Animal Health's Profit After Tax fell 10934.07% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 8243.9%. This contributed to the annual value of $338.0 million for FY2024, which is 12745.74% up from last year.
  • As of Q3 2025, Elanco Animal Health's Profit After Tax stood at -$34.0 million, which was down 10934.07% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Profit After Tax ranged from a high of $364.0 million in Q3 2024 and a low of -$1.1 billion during Q3 2023
  • Over the past 5 years, Elanco Animal Health's median Profit After Tax value was -$50.0 million (recorded in 2024), while the average stood at -$74.2 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 17968.75% in 2022, then tumbled by 158615.38% in 2023.
  • Elanco Animal Health's Profit After Tax (Quarter) stood at -$105.0 million in 2021, then surged by 48.57% to -$54.0 million in 2022, then crashed by 161.11% to -$141.0 million in 2023, then surged by 94.33% to -$8.0 million in 2024, then plummeted by 325.0% to -$34.0 million in 2025.
  • Its Profit After Tax was -$34.0 million in Q3 2025, compared to $11.0 million in Q2 2025 and $67.0 million in Q1 2025.